Regulation of transforming growth factor beta 1 gene expression by dihydropteridine reductase in kidney 293T cells

Biochemistry and Cell Biology

Volumn 91, Issue 3, 2013, Pages 187-193

  Gu, Yanting ^a   Gong, Yuewen ^b   Zhang, Haojun ^c   Dong, Xi ^c   Zhao, Tingting ^c   Burczynski, Frank J ^b   Wang, Guqi ^d   Sun, Sifan ^c   Zhu, Bin ^c   Han, Wenbing ^c   Wang, Hongpan ^c   Li, Ping ^c  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^c UNIVERSITY OF MANITOBA   (Canada)

^d CAROLINAS MEDICAL CENTER   (United States)

Author keywords

Diabetic nephropathy; Dihydropteridine reductase; NADPH oxidase; Tetrahydrobiopterin; TGF 1

Indexed keywords

DIABETIC NEPHROPATHY; DIHYDROPTERIDINE REDUCTASE; METABOLIC PATHWAYS; NADPH OXIDASE; NITRIC-OXIDE SYNTHASE; TETRAHYDROBIOPTERIN; TRANSFORMING GROWTH FACTOR BETA; WESTERN-BLOT ANALYSIS;

AMINO ACIDS; CLONING; COENZYMES; CYTOLOGY; DISEASES; GENE EXPRESSION; NITRIC OXIDE; RATS;

ENZYME INHIBITION;

CYCLOPHILIN B; DIHYDROPTERIDINE REDUCTASE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; KIDNEY CELL; KIDNEY CORTEX; NONHUMAN; PROTEIN URINE LEVEL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; CELL LINE; DIHYDROPTERIDINE REDUCTASE; DNA PRIMERS; GENE EXPRESSION; HUMANS; KIDNEY; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84881073671     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/bcb-2012-0087     Document Type: Article

References (22)

1. Block K. Ricono J.M. Lee D.Y. Bhandari B. Choudhury G.G. Abboud H.E. Gorin Y. 2006. Arachidonic Acid-Dependent Activation of a p22phox-Based NAD (P) H Oxidase Mediates Angiotensin II-induced Mesangial Cell Protein Synthesis and Fibronectin Expression via Akt/PKB. Antioxid. Redox Signal. 8 (9-10): 1497-1508. 10.1089/ars.2006.8.1497. 16987006.
2. Böttinger, E.P. 2007. TGF-β in Renal Injury and Disease. Elsevier.
3. Brosius F.C. 2008. New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy. Rev. Endocr. Metab. Disord. 9 (4): 245-254. 10.1007/s11154-008-9100-6. 18726161.
4. Choi Y.K. 2010. Mini Review: Alterations in dopamine and glutamate neurotransmission in tetrahydrobiopterin deficient spr-/-mice: relevance to schizophrenia. BMB Rep. 43 (9): 593-598. 10.5483/BMBRep.2010.43.9.593. 20846490.
5. Craven P.A. DeRubertis F.R. Melhem M. 1997. Nitric oxide in diabetic nephropathy. Kidney Int. Suppl. 60: 46-53. 9285902.
6. Davies M. Prime S.S. Eveson J.W. Price N. Ganapathy A. D'Mello A. Paterson I.C. 2012. Transforming growth factor-β enhances invasion and metastasis in Ras-transfected human malignant epidermal keratinocytes. Int. J. Exp. Pathol. 93 (2): 148-156. 10.1111/j.1365-2613.2011.00806.x. 3385707.
7. Delgado-Esteban M. Almeida A. Medina J.M. 2002. Tetrahydrobiopterin deficiency increases neuronal vulnerability to hypoxia. J. Neurochem. 82 (5): 1148-1159. 10.1046/j.1471-4159.2002.01055.x. 12358762.
8. .NO production through inhibiting NF-κB activation and BH4 biosynthesis in macrophages. Am. J. Physiol. Cell Physiol. 297 (3): C742-C749. 10.1152/ajpcell.00138.2009. 19553566.
9. Goumans M.J. Valdimarsdottir G. Itoh S. Rosendahl A. Sideras P. Ten Dijke P. 2002. Balancing the activation state of the endothelium via two distinct TGF-{beta} type I receptors. Science's STKE 21 (7): 1743-1753. 11927558.
10. Hanahan D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166 (4): 557-580. 10.1016/S0022-2836(83)80284-8. 6345791.
11. Hills C.E. S.P. 2011. The role of TGF-b and epithelial-to mesenchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev. 22 (3): 131-139. 10.1016/j.cytogfr.2011.06.002. 21757394.
12. Kanno Y. Into T. Lowenstein C.J. Matsushita K. 2008. Nitric oxide regulates vascular calcification by interfering with TGF-β signalling. Cardiovasc. Res. 77 (1): 221-230. 10.1093/cvr/cvm049. 18006450.
13. Lan H.Y. 2011. Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation. Int. J. Biol. Sci. 7 (7): 1056-1067. 10.7150/ijbs.7.1056. 21927575.
14. Lee C.K. Han J.S. Won K.J. Jung S.H. Park H.J. Lee H.M. et al. 2009. Diminished expression of dihydropteridine reductase is a potent biomarker for hypertensive vessels. Proteomics, 9 (21): 4851-4858. 10.1002/pmic.200800973. 19743417.
15. Möllsten A. Lajer M. Jorsal A. Tarnow L. 2009. The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes. Mol. Genet. Metab. 97 (1): 80-84. 10.1016/j.ymgme.2009.01.013. 19246226.
16. Ong H.B. Sienkiewicz N. Wyllie S. Fairlamb A.H. 2011. Dissecting the metabolic roles of pteridine reductase 1 in Trypanosoma brucei and Leishmania major. J. Biol. Chem. 286 (12): 10429-10438. 10.1074/jbc.M110.209593. 21239486.
17. Singh D.K. Winocour P. Farrington K. 2010. Oxidative stress in early diabetic nephropathy: fueling the fire. Nat. Rev. Endocrinol. 7 (3): 176-184. 10.1038/nrendo.2010.212. 21151200.
18. Slyvka Y. Wang Z. Yee J. Inman S.R. Nowak F.V. 2011. Antioxidant diet, gender and age affect renal expression of nitric oxide synthases in obese diabetic rats. Nitric Oxide, 24 (1): 50-60. 10.1016/j.niox.2010.11.004. 21094691.
19. Thöny B. Auerbach G. Blau N. 2000. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem. J. 347 (1): 1-16. 10.1042/0264-6021: 3470001. 10727395.
20. Wolf G. 2006. Renal injury due to renin-angiotensin-ldosterone system activation of the transforming growth factor-β pathway. Kidney Int. 70 (11): 1914-1919. 16985515.
21. Xia L. Wang H. Munk S. Kwan J. Goldberg H.J. Fantus I.G. Whiteside C.I. 2008. High glucose activates PKC-ζ and NADPH oxidase through autocrine TGF-β1 signaling in mesangial cells. Am. J. Physiol. Renal Physiol. 295 (6): F1705-F1714. 10.1152/ajprenal.00043.2008. 18815221.
22. Zhao T. Zhang H. Zhang X. Lu J. Yin T. Liang Q. et al. 2012. Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease. J. Pharm. Biomed. Anal. 60 (23): 32-43. 10.1016/j.jpba.2011.11.010. 22153801.